PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 6, 2026Open Forum Infectious Diseases0 citationsOpen Access

Scalability Metrics and Effort Requirements for a Long-Acting Injectable Antiretroviral Treatment Program

View Full Paper
JHJoshua P HavensNebraska Medical CenterJOJennifer O’NeillNebraska Medical CenterMKMaureen KubatNebraska Medical Center

Key Points

  • To assess the scalability metrics and effort requirements for a long-acting injectable antiretroviral treatment program.
  • Tracked patient enrollment over 2.5 years
  • Measured full-time equivalent staff effort
  • Evaluated program coordination and support activities
  • Scaled to 113 patients within 2.5 years
  • Required 2.25 full-time equivalents for implementation
  • Demonstrated favorable clinical outcomes throughout the program

Abstract

Abstract Implementation of a long-acting injectable antiretroviral treatment program requires substantial multidisciplinary effort, particularly for program coordination, coverage/billing, and patient support/retention. As our program scaled to 113 patients over 2.5 years, a total of 2.25 full-time equivalents were required. Despite operational demands, clinical outcomes were favorable, supporting real-world feasibility and scalability.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Havens et al. (2026) studied this question.

synapsesocial.com/papers/69aa70d6531e4c4a9ff5b018https://doi.org/10.1093/ofid/ofag116
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1P-1871. Scalability Metrics and Effort Requirements for a Long-Acting CAB/RPV Program2026
  2. 2Combined injectable regimens in treatment-experienced HIV/AIDS patients at a southern academic medical center: a case series2026
  3. 3Progress towards longer-acting antiretroviral regimens for adult HIV treatment2026
  4. 4Financial Impact of a Long-Acting Injectable Cabotegravir/Rilpivirine Program: A Real-World Experience2026
  5. 5Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system2024 · 3 citations